Newsroom Join us Citizenship Media gallery Company Products Partnerships Purpose Worldwide BIOSIMILAR FACILITY Setting a New Standard in Biosimilars Alvogen’s sister company, Alvotech, is a fully integrated specialty biopharmaceutical company focused exclusively on development and manufacturing of high-quality biosimilar medicines. They are specialists in biopharmaceutical product creation, all along the value chain from cell line development to commercial manufacturing. Visit Alvotech Fully integrated development Alvotech is focused on developing and bringing to market highest quality biosimilars. The current pipeline consists of biosimilar monoclonal antibodies aimed at treating cancer, autoimmune, inflammatory and other diseases. 01 Developement These products are developed in our four Research & Development centers located across Europe. 02 Production High-quality products will be manufactured in our state-of-the-art facility located in Reykjavik Iceland. 03 Release Partnership through Alvogen and key global players will be used to bring biosimilars to patients around the world. Company Products Partnerships Purpose Worldwide Citizenship Leadership team Contact us History Newsroom Media Gallery .st0{fill-rule:evenodd;clip-rule:evenodd;fill:#ffffff;} Terms of Use Privacy Policy Cookie Policy © 2021 Alvogen. All Rights Reserved

Newsroom Join us Citizenship Media gallery Company Products Partnerships Purpose Worldwide Board of Directors Robert Wessman - Chairman Tomas Ekman - CVC Partner Christoffer Sjöqvist - CVC Senior Director Ethan Park - Temasek Senior Director Andreas Rummelt - Independent Board Director Lars Molinder - Independent Board Director Company Products Partnerships Purpose Worldwide Citizenship Leadership team Contact us History Newsroom Media Gallery .st0{fill-rule:evenodd;clip-rule:evenodd;fill:#ffffff;} Terms of Use Privacy Policy Cookie Policy © 2021 Alvogen. All Rights Reserved